Integral Molecular Inc.
Philadelphia, PA
- UEI
- DY9KSWE8EJB8
- CAGE
- 3PJG4
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 25 N 38th St #800, Philadelphia, PA 19104, USA
- Website
- integralmolecular.com
- Founded
- 2001
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Acquisition of laboratory supplies on behalf of afrims, bangkok, thailand | Office of Acquisition Management | $30,290 | |
| Nichd: service: membrane proteome array screening service for novel monoclonal antibody target identification | National Institute of Child Health and Human Development | $66,900 | |
| Generation of pan-reactive antibody and cytokine reagents for immunologic analysis of bats - abstract understanding… | National Institute of Allergy and Infectious Diseases | $1,036,913 | |
| Antibody reagents for immunologic analysis of under-represented mammalian models | National Institute of Allergy and Infectious Diseases | $1,500,000 | |
| To discover and characterize b cell epitopes against the viral pathogens rvfv, cchfv, and EV-D68. | National Institute of Allergy and Infectious Diseases | $4,866,955 |
About Integral Molecular Inc.
Integral Molecular Inc. is a biotechnology company headquartered in Philadelphia, Pennsylvania, specializing in membrane protein research, therapeutic antibody development, and advanced biomedical technologies. The company provides sophisticated scientific services and research solutions to multiple federal agencies, focusing on innovative approaches in protein analysis, immunologic research, and drug development tools. As a for-profit organization registered in SAM.gov since 2004, Integral Molecular has established itself as a key provider of cutting-edge biomedical research services, with expertise in developing membrane proteome arrays, monoclonal antibody technologies, and advanced immunological reagents.
Through federal contract awards, Integral Molecular has consistently delivered specialized services across multiple scientific domains. The company has received contracts from agencies including the National Institute of Allergy and Infectious Diseases (NIAID), National Cancer Institute, National Institute of Child Health and Human Development, Defense Health Agency, and the Department of the Army. These contracts range from membrane proteome array screening services and antibody reagent development to laboratory supply procurement and virus particle acquisition. The contract awards demonstrate significant diversity, with total contract values ranging from $16,200 to $8,077,093, and include both small business set-aside and non-set-aside designations. Notably, many contracts focus on supporting infectious disease research, vaccine development, and immunologic analysis across various mammalian and non-mammalian models.
Integral Molecular's federal grant awards reveal a strategic focus on advanced biomedical research and technology development. The company has secured grants from agencies such as the National Institute of Allergy and Infectious Diseases, National Institute of General Medical Sciences, National Cancer Institute, National Institute on Aging, and National Institute of Neurological Disorders and Stroke. Grant projects encompass diverse research objectives, including developing pan-reactive monoclonal antibodies for bat immunology, creating specificity screening tools for biotherapeutic safety, generating rapid reporter viruses for viral pathogen studies, discovering antibodies against understudied membrane proteins, investigating cellular aging regulators for Alzheimer's disease prevention, and developing monoclonal antibodies for pain treatment. These grants, valued between approximately $495,061 and $600,000, consistently demonstrate Integral Molecular's commitment to innovative research with potential significant medical and therapeutic implications.
Quick answers
What is Integral Molecular Inc.'s UEI?
Integral Molecular Inc.'s Unique Entity ID (UEI) in SAM.gov is DY9KSWE8EJB8.
What is Integral Molecular Inc.'s CAGE code?
Integral Molecular Inc.'s CAGE code is 3PJG4.
What is Integral Molecular Inc.'s primary NAICS code?
Integral Molecular Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Integral Molecular Inc. located?
Integral Molecular Inc.'s physical address in SAM.gov is 25 N 38th St #800, Philadelphia, PA 19104, USA.
Is Integral Molecular Inc. registered in SAM.gov?
Yes. Integral Molecular Inc.'s SAM.gov registration is active through March 1, 2027.
What is Integral Molecular Inc.'s most recent federal award?
Integral Molecular Inc.'s most recent federal contract award is Acquisition of laboratory supplies on behalf of afrims, bangkok, thailand (19GE5026P0122), from Office of Acquisition Management, on September 22, 2026.
On GovTribe
See Integral Molecular Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors